Clinical Trial Update: Clinical Investigation to Evaluate the Hemanext® Oxygen Reduction System - Pivotal Trial [Phase 2]

View source ↗

Summary

A Phase 2 pivotal trial evaluating the Hemanext Oxygen Reduction System for whole blood donation and leukoreduction has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Whole Blood Donation and Leukoreduction

Drugs mentioned

• Hemanext Oxygen Reduction System

Snippet

Sponsor: Hemanext | Conditions: Whole Blood Donation and Leukoreduction | Phase 2 | Status: COMPLETED | Results posted: 2020-03-17